Effect of Delta Sleep-Inducing Peptide on Functional State of Hepatocytes in Rats During Restraint Stress.
Bobyntsev. I I II; Kryukov. A A AA; Belykh. A E AE; Dudka. V T VT
Key Findings
- 40 µg/kg DSIP increased catalase, SOD, and MDA in the liver during acute restraint stress in rats.
- During chronic stress, 40 µg/kg DSIP lowered catalase, SOD, and MDA, while 120 µg/kg DSIP reduced AST activity and raised total serum protein.
- The highest dose (360 µg/kg) showed no measurable impact on the measured liver parameters.
Practical Outcomes
- For biohackers, this suggests that very low doses of DSIP might modulate antioxidant defenses in stressful situations, but the effects are dose‑dependent and differ between short‑term and long‑term stress. However, the data are from rats only, so any human protocol would be speculative and should start with caution, low dosing, and close monitoring of liver markers if pursued.
Summary
In rats, a low dose (40 µg/kg) of delta sleep‑inducing peptide (DSIP) boosted liver antioxidant enzymes (catalase and SOD) during short‑term stress, but higher doses didn’t help. Under long‑term stress, the same low dose actually lowered those enzymes, while a mid dose (120 µg/kg) reduced a liver damage marker (AST) and raised total protein. The highest dose (360 µg/kg) had no effect.
Abstract
We studied the effect of delta sleep-inducing peptide (40, 120, and 360 μg/kg intraperitoneally, 1 h before the experiment) on free radical oxidation in the liver, aminotransferase activity, and total serum protein content in male Wistar rats during restraint stress. Treatment with the peptide in a dose of 40 μg/kg increased catalase and superoxide dismutase (SOD) activities and malonic dialdehyde (MDA) concentration in the liver homogenate of animals subjected to acute stress. No significant changes were found after administration of this peptide in other doses. Under conditions of chronic stress, the peptide in a dose of 40 μg/kg caused the most pronounced effect. Catalase and SOD activities and MDA concentration decreased, while aminotransferase activity and protein content remained unchanged under these conditions. Administration of the peptide in a dose of 120 μg/kg was accompanied by a decrease in SOD activity and MDA concentration, increase in total protein content, and reduction of AST activity. Increasing the peptide dose to 360 μg/kg abolished its effects.
Study Information
pubmed
2016
2016-02-23T00:00:00.000Z
10.1007/s10517-016-3186-8
3
23